版頭換這張2148285747

News

最新消息

已更新:

2025/12/14

分享至:

品牌中心

Mah Sing Group’s Healthcare Subsidiary (Mah Sing Healthcare) Visits G CLINIC International Medical System in Taiwan

Mah Sing Healthcare × G CLINIC International Medical System — Group Photo

 

Cross-Border Medical Collaboration kicks off

 

Following the previous trip by G CLINIC International Medical System (宸曜國際醫療體系) to Malaysia to participate in the Mah Sing Foundation’s charity Night for philanthropic and medical exchanges, Mah Sing Group’s healthcare business unit, Mah Sing Healthcare Sdn Bhd, has visited Taiwan this week to conduct a study tour and take the first step toward cross-border collaboration between the two parties.

 

The visit was led by Mah Sing’s senior management team, who gained in-depth understanding of G CLINIC’s clinical applications and operating model in the fields of precision medicine, regenerative medicine, and smart health management. This visit including:

 

Mah Sing Healthcare Team’s On-Site Visits to Clinics and Facilities

 

  • G CLINIC-Dunbei (Taipei) — Neurology & Regenerative Medicine Center
  • G CLINIC-Zhubei (Hsinchu) — Smart Metabolic Medicine Center
  • G CLINIC-Tzuwen (Taoyuan) — The System’s Newest Demo Clinic Site
  • Taipei Medical University | Proton Therapy Center
  • Cell Processing GTP Laboratory — High-Standard Cell Therapy Manufacturing Core

 

 


Photo at Zhubei clinic
G CLINIC–Zhubei (Hsinchu) — Smart Metabolic Medicine Center: Mah Sing team site visit

 

 

 

 

Understanding G CLINIC’s Medical Model: Precision × Regeneration × Smart Care

 

 

The Mah Sing team conducted multifaceted discussions on the overall operations of the G CLINIC International Medical System, including:

 

  • Clinic operation models within the medical system
  • International medical process, referral, and health management workflows
  • Integrated care across metabolic, circulatory, and neurological medicine
  • GTP-grade cell processing procedures, quality control, and safety standards

 

Through on-site observation, the Mah Sing team expressed strong recognition of Taiwan’s high standards in cell therapy and regenerative medicine, and conveyed great expectations for future collaboration between the two sides.

 

 


Photo at Taoyuan (Tzuwen) clinic
G CLINIC–Tzuwen (Taoyuan) — System’s newest demo clinic: on-site exchange with Mah Sing

 

 

 

The Start of Cross-Border Medical Collaboration: Two-way Interaction between Kuala Lumpur and Taiwan

 

 

This interaction symbolizes the deep connections between transnational healthcare systems. With a shared vision of enhancing healthcare across Asia, future directions of collaboration will include:

 

  • Overseas medical collaboration and healthcare service export
  • Introduction of health management center models
  • Establishment of a regenerative medicine and long-term care health ecosystem
  • Corporate health services and cross-border medical planning

 

For G CLINIC, this collaboration is not only the starting point of international partnership, but also an important milestone in bringing the “Taiwan medical care model” onto the global stage.

 


Visit to StemCyte Taiwan
Guided visit to StemCyte Taiwan with the Mah Sing Group — cell therapy manufacturing insights

 

 

 

 

Looking Ahead: Connecting More Cities with Taiwan’s Medical Capabilities

 

 

G CLINIC International Medical System will continue to build on its medical quality, clinical experience, and innovative services to work with international partners in promoting more comprehensive healthcare models, extending Taiwan’s medical capabilities to more cities and more families.

 

G CLINIC believes that medicine is not only about treating disease; it is also a vital force that helps people live healthier and with better quality of life.

【宸曜國際醫療體系官方Line】

本文著作權屬“ 宸曜國際醫療 ”所有,未經同意不得擅自轉載或引用。

回列表

其他文章